Clinical factors to predict a poor prognosis and refractory disease in patients with polymyositis and dermatomyositis associated with interstitial lung disease
Tada, Y.; Suematsu, E.; Ueda, A.; Nagano, S.; Sawabe, T.; Nishizaka, H.; Horiuchi, T.
Clinical and Experimental Rheumatology 30(3): 450
2012
ISSN/ISBN: 0392-856X PMID: 22325787 Document Number: 663431
Document emailed within 1 workday
Related Documents
Takizawa, H.; Hidaka, N.; Akiyama, K.; Hisatomi, T.; Kosuda, T.; Ishimitsu, T.; Miyachi, S.; Nishiwaki, M. 1985: Clinicopathological studies on interstitial lung disease in polymyositis-dermatomyositis Nihon Kyobu Shikkan Gakkai Zasshi 23(5): 528-536Hochberg, M.C.; Feldman, D.; Stevens, M.B.; Arnett, F.C.; Reichlin, M. 1984: Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease Journal of Rheumatology 11(5): 663-665
Saeki, T.; Suzuki, E.; Watanabe, T.; Saito, Y.; Itou, S.; Honma, T.; Sato, T.; Nakano, M.; Arakawa, M. 1994: Prognosis of interstitial pneumonitis (IP) in polymyositis (PM)/dermatomyositis (DM) Ryumachi 34(1): 16-21
Yuan, M-K.; Chang, C-Y.; Chang, S-C.; Chang, S-J.; Tang, G-J.; Wei, Y-F.; Liu, Y-C.; Chen, C-Y.; Yu, C-J. 2011: Imaging patterns and prognosis of patients with gefitinib-related interstitial lung disease International Journal of Clinical Pharmacology and Therapeutics 49(10): 587-593
Eissa, K.; Palomino, J. 2016: B-Cell Depletion Salvage Therapy in Rapidly Progressive Dermatomyositis Related Interstitial Lung Disease Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 168(3): 99-100
Narula, N.; Narula, T.; Mira-Avendano, I.; Wang, B.; Abril, A. 2018: Interstitial lung disease in patients with mixed connective tissue disease: pilot study on predictors of lung involvement Clinical and Experimental Rheumatology 36(4): 648-651
Li, R.; Li, X.-p.; Li, X.-m.; Wang, G.-s.; Qian, L.; Tao, J.-h.; Ma, Y.; Zhang, H. 2012: Predictive factors and unfavorable prognostic factorial analysis of interstitial lung disease in patients with inflammatory myopathy Zhonghua Yi Xue Za Zhi 92(33): 2335-2338
Gruhn, W.B.; Diaz-Buxo, J.A. 1987: Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermatomyositis/polymyositis Journal of Rheumatology 14(5): 1045-1047
Ogawa, N.; Shimoyama, K.; Kawabata, H.; Masaki, Y.; Wano, Y.; Sugai, S. 2003: Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders Ryumachi 43(1): 19-28
Adams, E.M.; Pucino, F.; Yarboro, C.; Hicks, J.E.; Thornton, B.; McGarvey, C.; Sonies, B.C.; Bartlett, M.L.; Villalba, M.L.; Fleisher, T.; Plotz, P.H. 1999: A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures Journal of Rheumatology 26(2): 352-360
Rodríguez Heredia, J.M.; García Toron, J.; Fontova Garrofe, R.; Alvarez Vega, J.L. 1988: Dermatomyositis and interstitial pulmonary disease Revista Clinica Espanola 183(8): 445
Santiago, M.B.; Chalhoub, M.; Pereira, S.T. 1998: Amyopathic dermatomyositis complicated by interstitial pulmonary disease and pneumomediastinum Journal of Rheumatology 25(10): 2042-2043
Peng, Q.-l.; Xie, Y.; Zhang, R.-f.; Shu, X.-m.; Wang, G.-c. 2012: The levels and clinical significance of serum B cell activating factor in Chinese patients with polymyositis or dermatomyositis Zhonghua Nei Ke Za Zhi 51(3): 210-213
Végh, J.; Szilasi, M.ár.; Soós, G.ör.; Dévényi, K.; Dezso, B.áz.; Soltész, P.ál.; Zeher, M.; Szegedi, G.; Bodolay, E. 2005: Interstitial lung disease in mixed connective tissue disease Orvosi Hetilap 146(48): 2435-2443
Kong, P.M.; Pinheiro, L.; Kaw, G.; Sittampalam, K.; Teo, C.H.Y. 2007: Erdheim-Chester disease: a rare cause of interstitial lung disease Singapore Medical Journal 48(2): e57-e59
Harmancy, E.; Gülbas, Z.; Ozdemir, N.; Elbek, O.; Mutlu, S.; Kolsuz, M.; Yurdasiper, A. 1998: T lymphocyte activation in bronchoalveolar lavage of patients with interstitial lung disease Allergie et Immunologie 30(8): 259-261
Shen, H.; Xia, L.; Lu, J. 2013: Interleukin-4 in rheumatoid arthritis patients with interstitial lung disease: a pilot study Indian Journal of Medical Research 138(6): 919-921
Lupanov, V.P.; Chotchaev, K.K.; Evstifeeva, S.E.; Deev, A.D.; Naumov, V.G. 2002: Clinical course of disease and prognosis in patients with ischemic heart disease with stable angina pectoris, caused by stenosing coronary atherosclerosis (data from a a 20-year study Terapevticheskii Arkhiv 74(9): 13-20
Stella, G.M.; Balestro, E.; Lacedonia, D.; Baraldo, S. 2016: Telomeropathies: an emerging spectrum of disorders with important implications for patients with interstitial lung disease Minerva Medica 107(1 Suppl. 1): 9-14
Paulin, F.; Doyle, T.J.; Fletcher, E.A.; Ascherman, D.P.; Rosas, I.O. 2015: Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis: Shared Mechanistic and Phenotypic Traits Suggest Overlapping Disease Mechanisms Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 67(5): 280-286